The International Society of Pharmacovigilance Vaccines Special Interest Group: Challenges and Opportunities Rebecca E. Chandler From the ISoP 09 May 2022 Pages: 597 - 599
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions Giovana R. OnziNathalia D’AgustiniAdriana R. Pohlmann Review Article 23 May 2022 Pages: 601 - 621
Hydroxyzine Initiation Following Drug Safety Advisories on Cardiac Arrhythmias in the UK and Canada: A Longitudinal Cohort Study Richard L. MorrowBarbara MintzesColin R. Dormuth Original Research Article Open access 19 April 2022 Pages: 623 - 638
Drug-Induced Sexual Dysfunction: An Analysis of Reports to a National Pharmacovigilance Database Carolina ValeiroCristiano MatosFlorence van Hunsel Original Research Article 07 April 2022 Pages: 639 - 650
Analysis of Reports on Adverse Drug Reactions Related to Herbal Medicinal Products and Herbal Supplements in the Netherlands Received by the National Pharmacovigilance Centre Lareb Florence P. A. M. van HunselDjurre van der KooiHerman J. Woerdenbag Original Research Article 24 May 2022 Pages: 651 - 661
Amyotrophic Lateral Sclerosis as an Adverse Drug Reaction: A Disproportionality Analysis of the Food and Drug Administration Adverse Event Reporting System Anna GaimariMichele FusaroliElisabetta Poluzzi Original Research Article 24 May 2022 Pages: 663 - 673
Montelukast and Nightmares: Further Characterisation Using Data from VigiBase Sarah WatsonElenor KaminskyQun-Ying Yue Original Research Article Open access 01 June 2022 Pages: 675 - 684
Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study Azza ShoaibiGowtham A. RaoPatrick B. Ryan Original Research Article Open access 02 June 2022 Pages: 685 - 698
